Why it Matters
The House Energy and Commerce Committee's Health Subcommittee is convening on March 18 to examine a question that touches every American's wallet: why does health care cost so much, and what role do providers play in the answer? The hearing — titled "Lowering Health Care Costs for All Americans: an Examination of the U.S. Provider Landscape" — arrives amid a surge of lobbying activity, bipartisan member engagement on affordability, and an ongoing congressional push to rein in spending across Medicare, Medicaid, and the commercial insurance market.
This is a fact-finding exercise meant to lay the groundwork for potential bills in the 119th Congress.
The timing reflects a convergence of pressures. Committee members from both parties have spent the past several weeks publicly flagging health care affordability as a top concern. Rep. Robin Kelly (D-IL) noted in February that "families are struggling to afford rent, food, and medical care," arguing that lowering costs should be the priority. Rep. Nick Langworthy (R-NY) pointed to ongoing Energy and Commerce work on prescription drug costs. Rep. Mariannette Miller-Meeks (R-IA) visited DaVita Dialysis in Pella, Iowa, to "hear directly from providers about how we can lower health care costs."
Meanwhile, Energy and Commerce Committee Chair Rep. Brett Guthrie (R-KY) has been sounding alarms about fraud in Medicare and Medicaid, calling the apparent schemes impacting the nation's health programs "outrageous." On the Democratic side, Ranking Member Rep. Diana DeGette (D-CO) and Rep. Gus Bilirakis (R-FL) jointly celebrated an FTC settlement with Express Scripts, a pharmacy benefit manager — a signal that PBM reform remains squarely in the subcommittee's crosshairs.
Rep. Jake Auchincloss (D-MA) has been pushing to defend federally qualified health centers from financial constraints tied to 340B drug pricing reform, while Rep. Frank Pallone (D-NJ) accused Republicans of "always prioritizing Big Pharma's profits at the expense of patients."
The breadth of these communications — 15 relevant public statements from 11 subcommittee members in just the first two weeks of February — signals that the Health Subcommittee hearing is part of a sustained effort.
A Lobbying Blitz on U.S. Provider Costs
The hearing's focus on the provider landscape sits at the center of one of Washington's most active lobbying battlegrounds. Federal lobbying disclosures from the third quarter of 2025 through the second quarter of 2026 reveal thousands of filings on topics directly tied to the hearing:
- Healthcare provider costs and hospital pricing: Approximately 4,262 filings, with major hospital systems including HCA Inc., Advocate Health Care, and Wake Forest Baptist Medical Center among the active filers.
- Site-neutral payment reform and physician fee schedules: Roughly 1,515 filings, with groups like the Large Urology Group Practice Association and the National Alliance of Safety-Net Hospitals weighing in.
- Health system mergers and market competition: About 3,105 filings, including from Fresenius Medical Care and Summa Health System.
- PBM reform and drug pricing: Approximately 1,451 filings, with PhRMA and Transparency-Rx Corp. among those engaged.
- Healthcare affordability and insurance: Around 2,013 filings, led by CVS Health, Blue Cross Blue Shield Association, and Centene Corp.
Roughly 3,047 filings specifically referenced the Energy and Commerce Committee or its Health Subcommittee, including from the Coalition Against Surprise Medical Billing.
Following the Money: PAC Contributions to Lawmakers
Seven organizations identified in the lobbying disclosures operate federal PACs that have collectively made an estimated 3,642 contributions to members of Congress. The scale is notable:
- CVS Health PAC: 750 FEC contribution records.
- BluePAC (Blue Cross Blue Shield Association): 761 records, with contributions to subcommittee member Rep. Lori Trahan (D-MA) among others.
- Centene Corporation PAC: 699 records.
- PhRMA Better Government Committee: 663 records.
- HCA Healthcare Good Government Fund: 292 records, including contributions to subcommittee Ranking Member Rep. Diana DeGette (D-CO) and Rep. Frank Pallone (D-NJ).
- Blue Shield of California PAC: 198 records, including contributions to subcommittee member Rep. Raul Ruiz (D-CA).
- Fresenius Medical Care North America PAC: 279 records, including contributions to Rep. Pallone.
All seven PACs contributed to both Republican and Democratic members. The heaviest targets were lawmakers on the Energy and Commerce, Ways and Means, and Senate Finance committees — the panels with direct jurisdiction over health care spending.
What to Watch
The hearing notice is available, but the witness list remains an open question. Key stakeholders likely to be called or referenced include representatives from hospital systems, insurance companies, physician groups, and patient advocacy organizations.
The hearing also arrives as the administration's health care policies face scrutiny. Rep. Robin Kelly warned in early February that "President Trump's cuts to Medicaid will push millions" off coverage, while Rep. John James (R-MI) praised the administration's "Trump Rx" initiative for delivering "medications directly to patients" and cutting "out the middlemen." Rep. Kim Schrier (D-WA) raised concerns about the firing of inspectors general overseeing health programs.
This health care costs hearing is an opening salvo, not a final vote. But with thousands of lobbying filings, millions in PAC contributions, and vocal engagement from members on both sides, the provider landscape examination is positioned to shape whatever legislation the Health Subcommittee produces next. For the millions of Americans navigating rising premiums, surprise bills, and shrinking provider networks, the question is whether this inquiry translates into action — or becomes another entry in a long record of hearings that go nowhere.
Access the Legis1 platform for comprehensive political news, data, and insights.